CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan DiaMedica Therapeutics Inc. - DMAC CFD

1.3791
3.66%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.1118
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.3304
Open* 1.2711
1-Year Change* -54.77%
Day's Range* 1.2711 - 1.4676
52 wk Range 1.12-3.23
Average Volume (10 days) 44.41K
Average Volume (3 months) 1.29M
Market Cap 36.76M
P/E Ratio -100.00K
Shares Outstanding 26.44M
Revenue N/A
EPS -0.50
Dividend (Yield %) N/A
Beta 1.76
Next Earnings Date Mar 13, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 8, 2023 1.3791 0.0884 6.85% 1.2907 1.4676 1.2711
Feb 7, 2023 1.3304 0.0686 5.44% 1.2618 1.3502 1.2222
Feb 6, 2023 1.2915 0.0303 2.40% 1.2612 1.3007 1.2612
Feb 3, 2023 1.3208 0.0201 1.55% 1.3007 1.3402 1.2608
Feb 2, 2023 1.3501 0.0497 3.82% 1.3004 1.3501 1.2619
Feb 1, 2023 1.3205 -0.0096 -0.72% 1.3301 1.3502 1.2905
Jan 31, 2023 1.3205 -0.0479 -3.50% 1.3684 1.3886 1.3198
Jan 30, 2023 1.3696 -0.0680 -4.73% 1.4376 1.4378 1.3691
Jan 27, 2023 1.4285 0.0597 4.36% 1.3688 1.4382 1.3688
Jan 26, 2023 1.4086 -0.0188 -1.32% 1.4274 1.4871 1.3691
Jan 25, 2023 1.4871 0.0400 2.76% 1.4471 1.4969 1.4274
Jan 24, 2023 1.4868 0.0001 0.01% 1.4867 1.5163 1.4867
Jan 23, 2023 1.5163 0.0888 6.22% 1.4275 1.5166 1.4273
Jan 20, 2023 1.5165 0.0602 4.13% 1.4563 1.5360 1.4272
Jan 19, 2023 1.5066 0.0793 5.56% 1.4273 1.5361 1.4273
Jan 18, 2023 1.5357 0.0103 0.68% 1.5254 1.5946 1.4565
Jan 17, 2023 1.5851 0.0101 0.64% 1.5750 1.6046 1.5453
Jan 13, 2023 1.5850 0.0297 1.91% 1.5553 1.5948 1.5552
Jan 12, 2023 1.5654 0.0494 3.26% 1.5160 1.5655 1.5160
Jan 11, 2023 1.5459 -0.0195 -1.25% 1.5654 1.5753 1.4961

DiaMedica Therapeutics Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 0.5 0 0 0
Total Operating Expense 2.48146 4.519 7.261 11.593 12.699 13.646
Selling/General/Admin. Expenses, Total 0.71805 1.313 2.739 3.693 4.389 4.881
Research & Development 1.7612 3.206 4.522 7.9 8.31 8.765
Depreciation / Amortization 0.00221
Operating Income -2.48146 -4.519 -6.761 -11.593 -12.699 -13.646
Interest Income (Expense), Net Non-Operating 0.06302 0.009 -0.039 0
Other, Net 0.21761 0.25 1.146 0.975 0.434 0.082
Net Income Before Taxes -2.20083 -4.26 -5.654 -10.618 -12.265 -13.564
Net Income After Taxes -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Net Income Before Extra. Items -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Net Income -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Income Available to Common Excl. Extra. Items -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Income Available to Common Incl. Extra. Items -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Diluted Net Income -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Diluted Weighted Average Shares 4.73575 5.93579 7.74352 11.9877 15.6803 20.7734
Diluted EPS Excluding Extraordinary Items -0.46944 -0.71768 -0.74049 -0.88833 -0.78391 -0.6543
Diluted Normalized EPS -0.46944 -0.71768 -0.74049 -0.88833 -0.78391 -0.6543
Revenue 0 0.5 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Total Operating Expense 3.619 3.365 3.416 3.246 3.536
Selling/General/Admin. Expenses, Total 1.213 1.209 1.084 1.375 1.562
Research & Development 2.406 2.156 2.332 1.871 1.974
Operating Income -3.619 -3.365 -3.416 -3.246 -3.536
Other, Net 0.004 0.098 -0.027 0.007 0.035
Net Income Before Taxes -3.615 -3.267 -3.443 -3.239 -3.501
Net Income After Taxes -3.622 -3.274 -3.45 -3.246 -3.508
Net Income Before Extra. Items -3.622 -3.274 -3.45 -3.246 -3.508
Net Income -3.622 -3.274 -3.45 -3.246 -3.508
Income Available to Common Excl. Extra. Items -3.622 -3.274 -3.45 -3.246 -3.508
Income Available to Common Incl. Extra. Items -3.622 -3.274 -3.45 -3.246 -3.508
Diluted Net Income -3.622 -3.274 -3.45 -3.246 -3.508
Diluted Weighted Average Shares 18.7667 18.7862 19.0357 26.5021 26.4431
Diluted EPS Excluding Extraordinary Items -0.193 -0.17428 -0.18124 -0.12248 -0.13266
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.193 -0.17428 -0.18124 -0.12248 -0.13266
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 1.85356 1.494 17.972 8.836 27.921 45.439
Cash and Short Term Investments 1.73636 1.353 16.823 7.878 27.507 45.112
Cash 1.73636 1.353 16.823 3.883 7.409 4.707
Total Receivables, Net 0.05197 0.08 0.78 0.823 0.34 0.13
Prepaid Expenses 0.06522 0.061 0.369 0.047 0.064 0.084
Total Assets 1.87295 1.802 18.339 9.053 28.095 45.551
Property/Plant/Equipment, Total - Net 0.0194 0.037 0.096 0.217 0.174 0.112
Property/Plant/Equipment, Total - Gross 0.0422 0.26 0.231 0.179
Accumulated Depreciation, Total -0.0228 -0.043 -0.057 -0.067
Total Current Liabilities 0.62697 1.003 1.296 1.318 2.028 1.524
Accounts Payable 0.32663 0.182 1.099 0.509
Accrued Expenses 0.24533 1.13 0.923 1.011
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 0.05501 0.084 0
Total Liabilities 0.62697 1.003 1.314 1.436 2.081 1.527
Total Long Term Debt 0 0 0.018 0.013 0.007 0.003
Other Liabilities, Total 0 0.105 0.046 0
Total Equity 1.24599 0.799 17.025 7.617 26.014 44.024
Common Stock 40.9937 0 0 0 0 0
Additional Paid-In Capital 6.21111 41.033 62.993 64.232 94.925 126.576
Retained Earnings (Accumulated Deficit) -46.5459 -40.234 -45.968 -56.617 -68.909 -82.501
Other Equity, Total 0.58708 0.002 -0.002 -0.051
Total Liabilities & Shareholders’ Equity 1.87295 1.802 18.339 9.053 28.095 45.551
Total Common Shares Outstanding 5.52605 6.37066 11.9569 12.0069 18.7462 26.4431
Accounts Receivable - Trade, Net 0.08 0.78 0.13
Other Long Term Assets, Total 0.271 0.271 0
Payable/Accrued 0.919 1.291
Current Port. of LT Debt/Capital Leases 0 0.005 0.006 0.006 0.004
Capital Lease Obligations 0 0.018 0.013 0.007 0.003
Short Term Investments 3.995 20.098 40.405
Other Current Assets, Total 0.088 0.01 0.113
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 24.195 21.629 48.537 45.439 42.111
Cash and Short Term Investments 23.401 21.295 48.097 45.112 41.047
Cash 3.329 2.228 16.219 4.707 3.032
Short Term Investments 20.072 19.067 31.878 40.405 38.015
Total Receivables, Net 0.337 0.016 0.104 0.13 0.168
Prepaid Expenses 0.457 0.318 0.336 0.084 0.793
Total Assets 24.356 21.774 48.664 45.551 42.211
Property/Plant/Equipment, Total - Net 0.161 0.145 0.127 0.112 0.1
Property/Plant/Equipment, Total - Gross 0.209 0.199 0.187 0.179 0.162
Accumulated Depreciation, Total -0.048 -0.054 -0.06 -0.067 -0.062
Total Current Liabilities 1.178 1.44 1.624 1.524 1.434
Accounts Payable 0.689 0.239 0.699 0.509 0.433
Accrued Expenses 0.483 1.196 0.921 1.011 0.995
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.006 0.005 0.004 0.004 0.006
Total Liabilities 1.211 1.456 1.628 1.527 1.443
Total Long Term Debt 0.005 0.005 0.004 0.003 0.009
Capital Lease Obligations 0.005 0.005 0.004 0.003 0.009
Other Liabilities, Total 0.028 0.011 0 0
Total Equity 23.145 20.318 47.036 44.024 40.768
Common Stock 0 0 0 0 0
Additional Paid-In Capital 95.68 96.126 126.296 126.576 126.884
Retained Earnings (Accumulated Deficit) -72.531 -75.805 -79.255 -82.501 -86.009
Other Equity, Total -0.004 -0.003 -0.005 -0.051 -0.107
Total Liabilities & Shareholders’ Equity 24.356 21.774 48.664 45.551 42.211
Total Common Shares Outstanding 18.7862 18.7862 26.4392 26.4431 26.4431
Accounts Receivable - Trade, Net 0.13 0.166
Other Current Assets, Total 0.113 0.103
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -2.22314 -4.26 -5.734 -10.649 -12.292 -13.592
Cash From Operating Activities -3.02318 -3.9 -5.696 -9.102 -9.185 -12.252
Cash From Operating Activities 0.0022 0.004 0.015 0.021 0.021 0.024
Non-Cash Items 0.14174 0.4 0.659 1.139 1.891 1.777
Cash Interest Paid 0.02552 0.002 0.002
Changes in Working Capital -0.94397 -0.044 -0.636 0.387 1.195 -0.461
Cash From Investing Activities -0.00689 -0.022 -0.05 -3.908 -16.134 -20.537
Capital Expenditures -0.00689 -0.022 -0.05 -0.002 -0.047 -0.022
Cash From Financing Activities 4.59263 3.539 21.216 0.07 28.845 30.087
Issuance (Retirement) of Stock, Net 4.59263 3.539 21.216 0.075 28.85 30.093
Foreign Exchange Effects 0.00767
Net Change in Cash 1.57023 -0.383 15.47 -12.94 3.526 -2.702
Cash Taxes Paid 0.026 0.036 0.028
Other Investing Cash Flow Items, Total -3.906 -16.087 -20.515
Issuance (Retirement) of Debt, Net -0.005 -0.005 -0.006
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -3.622 -6.896 -10.346 -13.592 -3.508
Cash From Operating Activities -4.313 -6.402 -9.448 -12.252 -3.888
Cash From Operating Activities 0.006 0.012 0.018 0.024 0.006
Non-Cash Items 0.551 1.023 1.354 1.777 0.443
Changes in Working Capital -1.248 -0.541 -0.474 -0.461 -0.829
Cash From Investing Activities -0.009 0.98 -11.848 -20.537 2.214
Capital Expenditures -0.009 -0.013 -0.015 -0.022 0
Other Investing Cash Flow Items, Total 0 0.993 -11.833 -20.515 2.214
Cash From Financing Activities 0.242 0.241 30.106 30.087 -0.001
Issuance (Retirement) of Stock, Net 0.244 0.244 30.111 30.093 0
Issuance (Retirement) of Debt, Net -0.002 -0.003 -0.005 -0.006 -0.001
Net Change in Cash -4.08 -5.181 8.81 -2.702 -1.675
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
EQT Partners AB Private Equity 10.8 2855847 304827 2022-07-08 LOW
Trill AB,LLC. Corporation 9.6472 2551020 2551020 2021-09-28
Jacinto (Richard II) Individual Investor 9.4543 2500000 850947 2022-12-31 LOW
Lytton (Laurence W) Individual Investor 4.0539 1071970 -308296 2021-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.9597 782640 0 2022-09-30 LOW
Giuffre (Randall Michael) Individual Investor 1.4983 396184 35130 2023-01-03 LOW
Omega Advisors, Inc. Investment Advisor 1.1345 300000 100000 2021-12-31 LOW
Jacob Asset Management of New York, LLC Investment Advisor 0.9019 238500 0 2022-09-30 LOW
Pilnik (Richard D) Individual Investor 0.7937 209882 55555 2023-01-03 LOW
Lynch (Timothy Patrick) Individual Investor 0.7573 200259 0 2021-12-31
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7004 185219 8197 2022-09-30 LOW
Burroughs (Amy Louise) Individual Investor 0.2772 73288 17156 2023-01-03 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.2617 69198 -11450 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.252 66629 0 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2455 64930 2153 2022-09-30 LOW
Pauls (Dietrich John) Individual Investor 0.211 55804 20000 2022-11-16 LOW
Alcorn Harry W Jr Individual Investor 0.1663 43981 399 2022-03-22 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.1612 42634 -15381 2022-09-30 LOW
Morgan Stanley & Co. LLC Research Firm 0.1589 42007 5207 2022-09-30 MED
Two Sigma Investments, LP Hedge Fund 0.1491 39418 -4531 2022-09-30 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+500000+

Trader

93000+

Klien aktif per bulan

$57000000+

Volume investasi per bulan

$31000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

22,779.20 Price
-1.510% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 60.00

XRP/USD

0.40 Price
-1.180% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 0.00351

US100

12,643.60 Price
+1.040% 1D Chg, %
Biaya inap posisi Long -0.0190%
Biaya inap posisi short 0.0076%
Waktu biaya inap 22:00 (UTC)
Spread 1.8

Oil - Crude

78.36 Price
-0.430% 1D Chg, %
Biaya inap posisi Long -0.0163%
Biaya inap posisi short 0.0021%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda